# Artificial Intelligence Based Melanoma Early Diagnosis and Risk Prediction in Children, Adolescents and Young Adults

> **NCT06621810** · — · RECRUITING · sponsor: **German Cancer Research Center** · enrollment: 3000 (estimated)

## Conditions studied

- Melanoma (Skin Cancer)
- Artificial Intelligence (AI)
- Pediatric Cancer

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT06621810
- **Lead sponsor:** German Cancer Research Center
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2022-12-01
- **Primary completion:** 2026-11-30
- **Final completion:** 2026-11-30
- **Target enrollment:** 3000 (ESTIMATED)
- **Last updated:** 2024-10-01

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06621810

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06621810, "Artificial Intelligence Based Melanoma Early Diagnosis and Risk Prediction in Children, Adolescents and Young Adults". Retrieved via AI Analytics 2026-07-17 from https://api.ai-analytics.org/clinical/NCT06621810. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*